1-on-1 with David Johnson: Enveric's Endocannabinoid Products for Glioblastoma
Season 1, Episode 21, Apr 12, 2021, 01:00 PM
In this episode, CancerNetwork sat down for a conversation with David Johnson, chairman and CEO of Enveric Biosciences. Johnson gave a thorough background of the biosciences company, and detailed the endocannabinoid products Enveric is developing to positively impact the quality of life for patients with glioblastoma.
Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast anywhere podcasts are available.
Don’t forget to subscribe to the "Oncology Peer Review On-The-Go" podcast anywhere podcasts are available.